
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2–Mediated COVID-19
J. Martijn Bos, Virginia B. Hebl, Ann L. Oberg, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 7, pp. 1354-1368
Open Access | Times Cited: 59
J. Martijn Bos, Virginia B. Hebl, Ann L. Oberg, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 7, pp. 1354-1368
Open Access | Times Cited: 59
Showing 1-25 of 59 citing articles:
COVID-19 and Cardiovascular Disease
Mina K. Chung, David A. Zidar, Michael R. Bristow, et al.
Circulation Research (2021) Vol. 128, Iss. 8, pp. 1214-1236
Open Access | Times Cited: 351
Mina K. Chung, David A. Zidar, Michael R. Bristow, et al.
Circulation Research (2021) Vol. 128, Iss. 8, pp. 1214-1236
Open Access | Times Cited: 351
SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis
Adam L. Bailey, Oleksandr Dmytrenko, Lina Greenberg, et al.
JACC Basic to Translational Science (2021) Vol. 6, Iss. 4, pp. 331-345
Open Access | Times Cited: 165
Adam L. Bailey, Oleksandr Dmytrenko, Lina Greenberg, et al.
JACC Basic to Translational Science (2021) Vol. 6, Iss. 4, pp. 331-345
Open Access | Times Cited: 165
COVID-19–Associated Nonocclusive Fibrin Microthrombi in the Heart
Melanie C. Bois, Nicholas Boire, Andrew J. Layman, et al.
Circulation (2020) Vol. 143, Iss. 3, pp. 230-243
Open Access | Times Cited: 155
Melanie C. Bois, Nicholas Boire, Andrew J. Layman, et al.
Circulation (2020) Vol. 143, Iss. 3, pp. 230-243
Open Access | Times Cited: 155
Crosstalk between the renin–angiotensin, complement and kallikrein–kinin systems in inflammation
Zivile Békássy, Ingrid Lopatko Fagerström, Michael Bäder, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 7, pp. 411-428
Open Access | Times Cited: 120
Zivile Békássy, Ingrid Lopatko Fagerström, Michael Bäder, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 7, pp. 411-428
Open Access | Times Cited: 120
Prediction of COVID-19 manipulation by selective ACE inhibitory compounds of Potentilla reptant root: In silico study and ADMET profile
Yuan Xu, Mahmood Al-Mualm, Ermias Mergia Terefe, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 7, pp. 103942-103942
Open Access | Times Cited: 39
Yuan Xu, Mahmood Al-Mualm, Ermias Mergia Terefe, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 7, pp. 103942-103942
Open Access | Times Cited: 39
Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2
Morag J. Young, Colin D. Clyne, Karen E. Chapman
Journal of Endocrinology (2020) Vol. 247, Iss. 2, pp. R45-R62
Open Access | Times Cited: 59
Morag J. Young, Colin D. Clyne, Karen E. Chapman
Journal of Endocrinology (2020) Vol. 247, Iss. 2, pp. R45-R62
Open Access | Times Cited: 59
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System
Matthew A. Sparks, Andrew M. South, Andrew D. Badley, et al.
Hypertension (2020) Vol. 76, Iss. 5, pp. 1350-1367
Open Access | Times Cited: 52
Matthew A. Sparks, Andrew M. South, Andrew D. Badley, et al.
Hypertension (2020) Vol. 76, Iss. 5, pp. 1350-1367
Open Access | Times Cited: 52
Multi-Omic Architecture of Obstructive Hypertrophic Cardiomyopathy
Ramin Garmany, J. Martijn Bos, David J. Tester, et al.
Circulation Genomic and Precision Medicine (2023) Vol. 16, Iss. 2
Open Access | Times Cited: 19
Ramin Garmany, J. Martijn Bos, David J. Tester, et al.
Circulation Genomic and Precision Medicine (2023) Vol. 16, Iss. 2
Open Access | Times Cited: 19
Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies
Girish Pathangey, Priyal Fadadu, Alexandra R. Hospodar, et al.
AJP Lung Cellular and Molecular Physiology (2020) Vol. 320, Iss. 3, pp. L301-L330
Open Access | Times Cited: 46
Girish Pathangey, Priyal Fadadu, Alexandra R. Hospodar, et al.
AJP Lung Cellular and Molecular Physiology (2020) Vol. 320, Iss. 3, pp. L301-L330
Open Access | Times Cited: 46
Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
Huseyin C. Yalcin, Vijayakumar Sukumaran, Mahmoud Khatib A. A. Al-Ruweidi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6703-6703
Open Access | Times Cited: 39
Huseyin C. Yalcin, Vijayakumar Sukumaran, Mahmoud Khatib A. A. Al-Ruweidi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6703-6703
Open Access | Times Cited: 39
Severe SARS-CoV-2 Infection in a Cat with Hypertrophic Cardiomyopathy
Francisco R. Carvallo, Mathias Martins, Lok R. Joshi, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1510-1510
Open Access | Times Cited: 37
Francisco R. Carvallo, Mathias Martins, Lok R. Joshi, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1510-1510
Open Access | Times Cited: 37
MBNL2 promotes aging-related cardiac fibrosis via inhibited SUMOylation of Krüppel-like factor4
Jing Lü, Qi Zhao, Lu Wang, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110163-110163
Open Access | Times Cited: 5
Jing Lü, Qi Zhao, Lu Wang, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110163-110163
Open Access | Times Cited: 5
Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy
Styliani Vakrou, Yamin Liu, Li Zhu, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 30
Styliani Vakrou, Yamin Liu, Li Zhu, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 30
Identification and verification of IGFBP3 and YTHDC1 as biomarkers associated with immune infiltration and mitophagy in hypertrophic cardiomyopathy
Yao Li, Wei Zhang, Yan Dai, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 19
Yao Li, Wei Zhang, Yan Dai, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 19
SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19
Daniel J. Clemens, Dan Ye, Wei Zhou, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282151-e0282151
Open Access | Times Cited: 12
Daniel J. Clemens, Dan Ye, Wei Zhou, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282151-e0282151
Open Access | Times Cited: 12
The molecular and cellular landscape of hypertrophic cardiomyopathy phenotypes: transition from obstructive to end-stage heart failure
Jude Taylor, Sean Lal, Filip Braet, et al.
Journal of Molecular Medicine (2025)
Closed Access
Jude Taylor, Sean Lal, Filip Braet, et al.
Journal of Molecular Medicine (2025)
Closed Access
Neurological Implications of COVID-19: Role of Redox Imbalance and Mitochondrial Dysfunction
Ravinder K. Kaundal, Anil Kumar Kalvala, Ashutosh Kumar
Molecular Neurobiology (2021) Vol. 58, Iss. 9, pp. 4575-4587
Open Access | Times Cited: 22
Ravinder K. Kaundal, Anil Kumar Kalvala, Ashutosh Kumar
Molecular Neurobiology (2021) Vol. 58, Iss. 9, pp. 4575-4587
Open Access | Times Cited: 22
An epigenome‐wide DNA methylation study of patients with COVID‐19
Shengyu Zhou, Jintao Zhang, Jiawei Xu, et al.
Annals of Human Genetics (2021) Vol. 85, Iss. 6, pp. 221-234
Open Access | Times Cited: 22
Shengyu Zhou, Jintao Zhang, Jiawei Xu, et al.
Annals of Human Genetics (2021) Vol. 85, Iss. 6, pp. 221-234
Open Access | Times Cited: 22
Bioinformatics and Immune Infiltration Analyses Reveal the Key Pathway and Immune Cells in the Pathogenesis of Hypertrophic Cardiomyopathy
Xuzhe Zhang, Si Zhang, Tingting Tang, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 22
Xuzhe Zhang, Si Zhang, Tingting Tang, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 22
A personalized mRNA signature for predicting hypertrophic cardiomyopathy applying machine learning methods
Jue Gu, Yamin Zhao, Yue Ben, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Jue Gu, Yamin Zhao, Yue Ben, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Application of omics technology to combat the COVID‐19 pandemic
Jingjing Yang, Yunzheng Yan, Wu Zhong
MedComm (2021) Vol. 2, Iss. 3, pp. 381-401
Open Access | Times Cited: 19
Jingjing Yang, Yunzheng Yan, Wu Zhong
MedComm (2021) Vol. 2, Iss. 3, pp. 381-401
Open Access | Times Cited: 19
Systematic identification of ACE2 expression modulators reveals cardiomyopathy as a risk factor for mortality in COVID-19 patients
Navchetan Kaur, Boris Oskotsky, Atul J. Butte, et al.
Genome biology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Navchetan Kaur, Boris Oskotsky, Atul J. Butte, et al.
Genome biology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Inflammatory endotypes of CRSwNP and responses to COVID-19
Ming Wang, Chengshuo Wang, Luo Zhang
Current Opinion in Allergy and Clinical Immunology (2020) Vol. 21, Iss. 1, pp. 8-15
Closed Access | Times Cited: 19
Ming Wang, Chengshuo Wang, Luo Zhang
Current Opinion in Allergy and Clinical Immunology (2020) Vol. 21, Iss. 1, pp. 8-15
Closed Access | Times Cited: 19
COVID-19 As An Endothelial Disease and Its Relationship to Vascular Endothelial Growth Factor (VEGF) and Iodide
Mika Turkia
SSRN Electronic Journal (2020)
Closed Access | Times Cited: 19
Mika Turkia
SSRN Electronic Journal (2020)
Closed Access | Times Cited: 19
Sex-Related Factors in Cardiovascular Complications Associated to COVID-19
Francesca Megiorni, Paola Pontecorvi, Giulia Gerini, et al.
Biomolecules (2021) Vol. 12, Iss. 1, pp. 21-21
Open Access | Times Cited: 18
Francesca Megiorni, Paola Pontecorvi, Giulia Gerini, et al.
Biomolecules (2021) Vol. 12, Iss. 1, pp. 21-21
Open Access | Times Cited: 18